论文部分内容阅读
目的:观察阿卡波糖(卡博平)治疗2型糖尿病的临床疗效。方法:选取住院和门诊的2型糖尿病患者100例,随机分为治疗组50例,对照组50例。两组基础治疗相同,治疗组加卡博平,对照组加拜糖苹,疗程均2个月。分别测定治疗前后血糖、糖化血红蛋白、甘油三酯、总胆固醇。结果:两组治疗后较治疗前血糖、糖化血红蛋白、甘油三酯有显著改善(P<0.05),两组治疗后各项指标比较,无统计学差异(P>0.05)。结论:两种阿卡波糖对治疗2型糖尿病有相同疗效。
Objective: To observe the clinical efficacy of acarbose in treatment of type 2 diabetes mellitus. Methods: 100 inpatients and outpatients with type 2 diabetes mellitus were randomly divided into treatment group (50 cases) and control group (50 cases). The same two groups of basic treatment, the treatment group plus carboprofen, the control group plus Baipi Ping, treatment were 2 months. Before and after treatment were measured blood glucose, glycosylated hemoglobin, triglycerides, total cholesterol. Results: The blood glucose, HbA1c and triglyceride were significantly improved after treatment in both groups (P <0.05). There was no significant difference between the two groups after treatment (P> 0.05). Conclusions: Both acarbose treatments have the same effect on type 2 diabetes mellitus.